Dr. Cheryl Genessa Cauthen, MD

Dr. Cauthen practices at Virginia Ophthalmology Associates in Norfolk, Virginia.

Dr. Cauthen's NPI, 1770546442, was assigned on April 11, 2006. Dr. Cauthen graduated from Howard University College Of Medicine in 1981. Dr. Cauthen holds Virginia license 0101034703.

Dr. Cauthen's primary practice is Virginia Ophthalmology Associates, at 885 Kempsville Rd, Norfolk, VA 23502 in Norfolk City. The practice phone is (757) 461-1444.

Dr. Cauthen's primary practice is Virginia Ophthalmology Associates in Norfolk, Virginia. Dmand AI also links Dr. Cauthen to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cauthen practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Cauthen's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Cauthen is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Cauthen's licenses on file in 2 states: Virginia and District of Columbia.

Dmand AI lists age-related macular degeneration, cataract, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Cauthen treats.

CMS data shows 2,929 Medicare services from Dr. Cauthen across 9 procedure codes in 2024, for 834 Medicare patients. Medicare paid $150,760 for them. Every service was in an office.

CMS counts 834 Medicare patients who saw Dr. Cauthen in 2024. The largest group is 65 to 74, with 347 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Cauthen's median patient age at 69, with 68% women.

In 2024, Dr. Cauthen wrote 2,919 Medicare Part D claims for 528 patients. 69% of them were for generic drugs. CMS names the drug for 2,818 of them, across 26 drugs with 11 or more claims each, at $478,907 in total drug cost. In 2023, CMS named 2,537 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Cauthen for performance year 2024, reported as part of a group. Dr. Cauthen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 22 procedures of cataract surgery by Dr. Cauthen, more than 47% of the clinicians it reports for that procedure.

CMS Open Payments shows 177 general payments to Dr. Cauthen from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Allergan Inc. paid the most, $2,093.

Dmand AI lists 2 awards for Dr. Cauthen, most recently AAO Fellow in 2013.

Dr. Cauthen graduated from Howard University College Of Medicine in 1981. Dr. Cauthen is a member of AAO.

Dr. Cauthen is in network with 20 carriers, including Aetna, Blue Cross Blue Shield of Michigan and HCSC. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.